Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

ProCell Surgical introduces new device for surgical sponge-blood recovery

ProCell Surgical introduces new device for surgical sponge-blood recovery

ProCell Surgical has launched a new medical device system ProCell that automates the manual activity of surgical sponge-blood recovery for intraoperative autotransfusion (IAT).

The new surgical sponge-blood recovery system ProCell has been designed to replace the traditional, manual activity with an automated, collection process, said the company.

ProCell Surgical CEO Robert Krensky said: โ€œProCell Surgicalโ€™s sponge blood recovery system brings the first automated innovation for sponge-blood recovery directly to the operating room table.

โ€œIt is easy to operate and can be used repeatedly during its single case use. ProCellโ„ข essentially closes the technology gap that existed during this important preliminary phase of IAT.โ€

The company said that hand-wringing is a time-consuming, ineffective, and is broadly variable depending on strength, technique, and stamina of the person.

In addition, the process often is associated with several drawbacks, including loss of blood from splatter and residual blood remaining on surgical gloves.

With a unique patented design ProCell would enhance the surgical blood conservation efforts. The system makes use of an operating roomโ€™s standard vacuum suction to apply a sustained compressive force that extracts blood from surgical sponges.

The recovered blood can be sent to the cell saver equipment through the deviceโ€™s own suction tubing, prior to the reinfusion into the patient during the same surgical procedure.

IAT is widely used in the operating room and has resulted in reduction in requirements for donor blood transfusions during surgery along with their associated risk and supply chain issues.

ProCell Surgical COO Mike Kehoe said: โ€œIn my 30 plus years of managing medical device companies, this is the first product that I have been involved with that is not only cost-effective and proprietary but represents a generational paradigm shift in the approach to conservation of blood during surgery.โ€

ProCell Surgical is a Canton, Massachusetts-based medical device company focused on developing and manufacturing advanced medical devices.

Yuma Regional Medical Center Partners with Medline to Improve Patient Outcomes through Enhanced Supply Chain Strategy

Yuma Regional Medical Center Partners with Medline to Improve Patient Outcomes through Enhanced Supply Chain Strategy

Medline announced a $12 million prime vendor partnership with Yuma Regional Medical Center, an acute care facility with 406 inpatient beds in Southwest Arizona. After being with a previous vendor for several decades, the two organizations will now identify new strategies for enhancing operational and clinical efficiencies across the acute care hospital and multiple ambulatory facilities.

โ€œYuma Regional Medical Center is always looking for cost saving opportunities to help improve patient outcomes without compromising product quality,โ€ says Sean Hazlett, director, supply chain services, Yuma Regional Medical Center. โ€œThe support and teamwork we have received from Medline during the transition period has been โ€˜best in classโ€™ and we look forward to many successful years to come.โ€

โ€œWeโ€™re pleased to start this new chapter working side-by-side with Yuma Regional Medical Center to help uncover new ways to free up more time and dollars for patient care,โ€ says John Abele, vice president, corporate sales, Medline.

About Medline

Medline is a healthcare company: a manufacturer, distributor and solutions provider focused on improving the overall operating performance of healthcare. Medline works with both the countryโ€™s largest healthcare systems and independent facilities across the continuum of care to provide the clinical and supply chain resources required for long-term financial viability in delivering high quality care. With the size of one of the countryโ€™s largest companies and the agility of a family-owned business, Medline is able to invest in its customers for the long-term and rapidly respond with customized solutions. Headquartered in Northfield, Ill., Medline has 26,000+ employees worldwide, a fleet of nearly 1,000 trucks and does business in more than 90 countries.

Reflow Medical Enrolls First Patients in the DEEPER LIMUS Study of the Temporary Spur Stent System

Reflow Medical Enrolls First Patients in the DEEPER LIMUS Study of the Temporary Spur Stent System

Reflow Medical, Inc., a California-based medical device company, has enrolled the first patients in A Non-Randomized Pilot Study of the Temporary Spur Stent System for the Treatment of Lesions Located in the InfraPoplitEal Arteries Using a LIMUS-base Drug-coated Balloon (DEEPER LIMUS). The OUS single center clinical trial (NCT04162418) is expected to enroll up to 30 participants and last approximately six months. It will follow primary and secondary endpoints for safety and efficacy.

The Temporary Spur Stent System is a novel retrievable stent designed to treat long, diffuse and severely calcified infrapopliteal disease. The device consists of a patented retrievable stent system having a series of radially expandable spikes designed to create multiple pathways to allow the increased uptake of antiproliferative drugs (โ€œlimusโ€ based) into the vessel wall and facilitate acute luminal gain, without leaving anything behind. The device was developed in response to unmet clinical needs in treating patients suffering from critical limb ischemia (CLI), a serious condition in below-the-knee (BTK) disease that can result in high rates of restenosis and further treatment challenges.

Marianne Brodmann, MD, a professor and vascular specialist at the Medical University of Graz, Austria, is the trialโ€™s principal investigator. โ€œThis gives us an opportunity to truly understand how differently anti-restenotic drugs can treat infrapopliteal disease,โ€ she commented. โ€œThe unique design of the Spur device may enable the anti-proliferative drug to reach the medial layers of the arterial wall, without leaving anything behind, and minimizing the need for follow-up procedures.โ€

Company Co-founder and CEO Isa Rizk noted, โ€œWe are excited to gather data to support the clinical use of the Spur Stent in conjunction with a limus-coated balloon. This new study data will be added to a portfolio of other studies completed or currently enrolling on this groundbreaking medical technology.โ€

About Reflow Medical, Inc.
Reflow Medical, Inc. is a private company focused on empowering physicians through the design and development of innovative and effective technologies for cardiovascular disease. Reflow is developing a family of products to treat cardiovascular disease.

Carrot Health and HealthMine Form Strategic Partnership to Improve Health Plan Performance and Member Satisfaction

Carrot Health and HealthMine Form Strategic Partnership to Improve Health Plan Performance and Member Satisfaction

Carrot Health, a leading provider of healthcare solutions powered by consumer data, and HealthMine, the health action engagement company, announced a strategic product integration partnership for the health plan market. By combining Carrot Healthโ€™s MarketViewโ„ข platform and consumer data analytics with HealthMineโ€™s engagement and rewards solution that empowers individuals to take the right actions to improve their health, this partnership creates a solution enabling health plans to improve performance and member satisfaction.

โ€œWe are all currently facing unique challenges that make it absolutely critical for health plans to reach every one of their members, right now, and guide them to the care they need,โ€ said HealthMine CEO Bryce Williams. โ€œThis partnership with Carrot Health will help accomplish that goal by aligning our capabilities to provide cost-effective solutions for plans to strategically scale their member engagement and satisfaction initiatives.โ€

By coupling advanced algorithms with population health and quality improvement disciplines, HealthMineโ€™s clinically-based analytic engagement solution helps plans thrive by targeting, motivating, and empowering individuals to take actions that improve clinical outcomes while decreasing total cost of care. Its engagement and rewards solution moves the needle with personalized health action plans delivering customizable rewards, with continuous monitoring and measurement of interventions for the plan.

โ€œCarrot Healthโ€™s mission is to enable a future with no barriers to better health. We believe that shining the bright light of data onto our disparities will help us, all working together, improve health,โ€ said Kurt Waltenbaugh, CEO, Carrot Health. โ€œOur partnership with HealthMine helps Carrotโ€™s customers take informed โ€˜last-mileโ€™ action to impact individuals. We are excited for the value this collaboration can bring to the market and the differences it enables for health plan members nationwide.โ€

Carrot Health is the only vendor delivering consumer insights, at scale, for every adult in the United States, along with individual-level Social Determinants of Health (SDoH) scoring and monitoring, for the healthcare industry. Carrot Healthโ€™s data include up to 5,000 individually identified variables, including consumer lifestyle and behavior, geocoding, and survey data.

Together, Carrot Health and HealthMine enable highly customized engagement strategies โ€“ targeting the right member with the right intervention at the right time and providing plan users with real-time, actionable insights. The partnership pairs the MarketView platformโ€™s comprehensive data-driven approach and consumer analytics with HealthMineโ€™s smart engagement platform, monitoring services, and digital outreach engagement solution, helping health plans maximize time, energy, and budget for improved results and program efficiencies.

About HealthMine
HealthMine is a leading engagement and reward solution, empowering individuals to take the right actions to improve their health. Creating personalized continuous engagement strategies for healthcare organizations down to the individual member and driving health actions through customized incentives and rewards; improving clinical outcomes and accelerating quality improvement โ€“ providing plan users real-time actionable insight in one configurable solution. Connect with HealthMine on LinkedIn and learn more at HealthMine.com.

About Carrot Health
Carrot Health believes in enabling a future with no barriers to better health, for everyone. We believe that shining the bright light of data onto our disparities will help us, all working together, to improve health. We provide consumer insights for each and every individual person in the United States to engage patients and members, close gaps in care, and optimize performance for healthcare payers and provider systems. The Carrot MarketViewโ„ข software platform incorporates social, behavioral, environmental, and economic barriers to health data to deliver a 360-degree view of the consumer, providing actionable insights to inform Growth, Health, and Quality.

Genetron Health Receives FDA Authorization for SARS-CoV-2 RNA Test and Approval for Export by Chinese Authority

Roche's SARS-CoV2 antibody test will help evaluate the patients immune response to the virus

Genetron Holdings Limited, a China-based precision oncology company that covers full-cycle cancer care, announced that its independently developed detection kit for the novel coronavirus (Genetron SARS-CoV-2 RNA Test) received Emergency Use Authorization (EUA) from the U.S. FDA. Additionally, the kit received approval for export from the relevant authorities in China.

Genetron Health was whitelisted as an approved COVID-19 reagent manufacturer by the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE), which means Genetron Health is granted to export Genetron SARS-CoV-2 RNA Test.

Prior to receiving the FDA EUA and being whitelisted by CCCMHPIE, Genetron SARS-CoV-2 RNA Test had already obtained CE marking (Registration Number: DE/CA20/IVD-Luxuslebenswelt-111/20); registration certification by European representative Luxus Lebenswelt GmbH; and its technical file also passed SGS review. All of these certifications indicate conformity with health, safety, and environmental protection standards for products sold within the European Economic Area.

Genetron SARS-CoV-2 RNA Test is an accurate, fast, contamination-free testing solution, which efficiently detects large-scale samples for the novel coronavirus. Features include:

Comprehensive and Accurate Testing: Genetron SARS-CoV-2 RNA Test detects two different and highly specific gene sequences of SARS-CoV-2: ORF1ab and N, which improves both its accuracy and specificity. It also includes an internal reference to prevent possible false negative results. Each test is capable of detecting SARS-CoV-2 RNA as low as 10 copies.
Easier to Operate and Less Time-Consuming: With patented technology, the One-Step Seq Method, the process integrates reverse transcription of viral RNA and quantitative PCR reaction in a single step. The entire process takes less than 2.5 hours, including only 10 minutes of hands-on time.
Contamination Free: The application of contamination resistant dUTP and UDG enzymes allows the system to degrade non-specific and nucleic acid-contaminated PCR products.

Genetron Health has supplied its SARS-CoV-2 RNA Test to some high-risk areas in the world to aid in their large-scale coronavirus testing. Genetron Health is committed to fighting and controlling the COVID-19 pandemic with high-quality testing products and diligent assistance.

About Genetron Health

Genetron Health is a leading and fast-growing precision oncology company in China that aims to provide one-stop genomic profiling solutions for multiple scenarios covering early screening, diagnosis and monitoring, and biopharmaceutical services. The company collaborates with over 500 hospitals and dozens of biopharmaceutical companies and research institutions, and has developed a large proprietary genomic database.

Genetron Health has established R&D centers in both the United States and China, two manufacturing facilities with both ISO 13485:2016 certification and ISO 9001 2015 certification in China and five clinical laboratories in Beijing (CLIA accreditation and CAP certification), Shanghai, Hangzhou, Chongqing and Guangzhou. The R&D capacities of Genetron Health are supported by a best-in-class research and development team led by scientists at the forefront of cancer genomics research. The company has published many research papers in highly influential worldwide peer-reviewed scientific journals, such as Nature Genetics, Nature Communications, Cell Research and PNAS.

Massages: How Often Should I Get One?

Massages: How Often Should I Get One?

Introduction

Getting a massage may be one of the most relaxing treats for your fatigued body and is presumably the top activity that one seeks after a long week at work or on a vacation. Massages can be solely for relaxation purposes, or they can be carried out by a massage therapist to treat medical conditions. While massages as a form of treatment may be required more frequently, there is no hard and fast rule stating that leisure massages should occur less often. Without further ado, let us dive into the facts that you need to know about massages and whether or not you are overdoing your weekly massage appointments.

What is ideal?

The frequency of massages required typically depends on the type of massage you are getting and the area that you are targeting. Massages that tackle pain or injury like Brisbane remedial massage are usually more effective when they are done more often, though every situation may differ from patient to patient. As for leisure massages, though they are not mandatory, they can be highly effective in reducing tension in muscle groups. However, they can be pricey especially if you plan on arranging for regular sessions. If you do not have the financial capability to do so, consider prolonging the duration between each session to maximize the benefits of each massage session, as well as learn massage techniques from your local massage therapist or masseuse.

Types of Massages

Lymphatic drainage massage

Extremely effective for draining lymph nodes that have been injured due to a medical condition or a recent surgery, the lymphatic drainage massage aims to regulate the flow of the fluid in the lymph nodes and reduce the fluid accumulated there. As this massage is meant for patients who have been injured or undergone surgery, this massage is typically effective when it is done every day in the beginning and can be reduced to about two or three times a week after the initial phase. Though this should only be done by certified massage therapists, you can learn some techniques that you can do yourself at home to speed up the recovery process.

Deep tissue massage

Usually done for patients who have injured various muscle groups, this massage aims to strengthen muscles by using forceful strokes to reach the deeper layers of connective tissue and muscles to facilitate recovery. Depending on each individualโ€™s needs, this type of massage can be done from once a day to a few times a month, according to the severity of the injury. Individuals should seek a professional to accurately recommend the duration and frequency for their own condition.

Scalp massage

Scalp massages are usually for relaxation purposes, as it is not only extremely soothing, but it can also reduce heart rate and blood pressure, resulting in lower tension and a decrease in stress levels. Regular scalp massages can be useful to maintain your overall mood and make you feel calm, and the frequency of such massages typically depends on your financial capability and amount of free time. The recommended frequency is about twice a week lasting for about 15 to 25 minutes.

Full-body massage

A general favorite for tourists who frequent places like Thailand and Malaysia, full-body massages are extremely relaxing and effective in reducing tension in all areas of your body. It calms your mind and helps you curb stress levels, though they should only be done occasionally, about once every few weeks or a month.

Massage chair

A more accessible type of massage, many individuals may choose to invest in a massage chair for their homes for temporary relief of tight or aching muscles. Typically lasting for about 10 to 30 minutes, massage chairs do have a host of positive benefits including a reduction in stress levels and more relaxed muscle groups.

Conditions

Back and neck pain

Pains in the back and neck will benefit from regular massage sessions, as these sessions focus on reducing tension and aches by opening up the muscles and using forceful strokes to curb the pain. These massages can usually be done every week or every two weeks until the tension and pain are fully eradicated.

Stress

Massages can induce lower stress levels and cause individuals to feel calmer and more relaxed. Individuals who suffer from chronic stress may find it useful to get a massage targeted at relieving stress once or twice a month for maximized results. Studies have shown that a 60-minute massage for relaxation has been proven to reduce cortisol levels by 30 percent and induce serotonin levels to increase by 28 percent, leading to a better overall mood and well-being.

Pregnancy

Pregnancy may come with a ton of discomforts, such as the more frequent leg and back pain. Professionals recommend getting a regular and light massage to reduce these aches and improve the mental state of the pregnant person. These massages can usually be done every week for 20 minutes either by a trained professional or by someone at home and are effective in curbing stress and relieving physical symptoms of pregnancy like pain and aches. Furthermore, massages during labor have also been found to be beneficial in reducing the time spent in labor and the medication required during labor.

Cautions

Though massages reap a host of benefits, there are certain conditions that may deem you unsafe for a massage session. These include broken or fractured bones, a bleeding disorder, osteoporosis, cancer, open wounds as well as other serious conditions. On top of that, pregnant individuals should also be advised against getting a massage in the first trimester and should get it done at their own discretion.

Conclusion

Massages are great for a whole list of benefits, including relieving pain, eradicating bodily aches, and even reducing stress levels. If you require regular massages to treat your injury, it is best to consult a doctor on the frequency and duration of each session that you need to effectively help you heal. If you are just seeking massages as a form of relaxation, they are usually best if you do them once a few weeks or a month. Depending on your situation, massages can be extremely useful in improving your overall well-being and making you feel more relaxed on a daily basis.

Tenacore welcomes Barbara Bitzer as new Chief Financial Officer

Tenacore welcomes Barbara Bitzer as new Chief Financial Officer

TENACORE announced that they have named Barbara Bitzer as the new chief financial officer effective May 18, 2020. In this role, Bitzer will lead the financial team to manage and execute the business financial plan and strategy. She will serve as a member of the Tenacore executive leadership team reporting to Chief Executive Officer James Willett.

Bitzer and her team will manage day to day financial operations and ensure alignment with the core business expansion strategy. Additionally, Barbara and her team will lead the companyโ€™s transition to entirely new service operations and enterprise resource planning (ERP) platforms.

This effort will enable Tenacore to fully reengineer current service and repair processes and transform the service line capabilities. This transformation will position Tenacore with best-in-class service and repair systems infrastructure, enabling customers to better manage asset repair costs.

โ€œWe are incredibly fortunate to have Barb join the Tenacore team and lead our financial initiatives that will help transform this business into a leading force within medical device depot service,โ€ says James Willett, chief executive officer. โ€œHer experience in both large and small business environments combined with leading multiple acquisitions and integrations make Barb a tremendously important addition to our team.โ€

Bitzer most recently served as chief accounting officer and senior controller for Foundation Building Materials, Inc., located in Santa Ana, CA. In this role she was responsible for all accounting, SEC and external reporting. She also led the audit committee reporting to the Board of Directors and established a SOX compliant internal control structure in the newly established public company. Barbara has also served as vice president and controller for both Calumet Specialty Products, L.P. and Remy International, where she led accounting and treasury functions, as well as leading accounting due diligence for acquisition projects.

โ€œIโ€™m looking forward to joining the Tenacore organization and the leadership team that will move Tenacore to the next level of growth within the medical device service and repair industry,โ€ said Bitzer. โ€œThis is a tremendous market where I am confident that Tenacore will grow to become an even more important provider of new asset management and repair solutions for our clients and the patients that they serve.โ€

Bitzer earned a Bachelor of Science degree from The University of Evansville, Evansville, IN. She is a CPA and volunteer board member with the Pretend City Childrenโ€™s Museum in Irvine, CA.

About Tenacore
Tenacore LLC is a healthcare technology management company specializing in the depot based service and repair of a broad range of medical equipment. The companyโ€™s ongoing expansion across the United States, paired with its depot model, multi-vendor service expertise and scalability, uniquely positions Tenacore to offer a cost effective and quality alternative to site-based service. In February of 2020, The Courtney Group based in Newport, CA collaborated with Indianapolis based Centerfield Capital Partners to invest in the acquisition of Tenacore LLC.

EKF opens for live chats at ENDO Online 2020

EKF opens for live chats at ENDO Online 2020

EKF Diagnostics, the global in vitro diagnostics company, announces that its online exhibition booth at this yearโ€™s ENDO Online 2020 is open for live chats on its range of diagnostics products for glycemic monitoring and ketosis testing from 10 – 17th June.

Organized by the Endocrine Society, ENDO Online 2020 runs from 8 – 20th June featuring a combination of live and on-demand programming, as well as its virtual Exhibit Hall. This gives researchers and clinicians access to the latest information within the field of endocrinology without having to leave their office. As the COVID-19 pandemic has canceled many meetings, making access to learning opportunities and new science challenging, visitors can register for free online access to ENDO Online 2020.

On EKFโ€™s booth – EKF – visitors will be able to find out about the Companyโ€™s line of diagnostic tests and analyzers used in glycemic monitoring and ketosis. These products are used in laboratories, hospitals and clinics worldwide. Visitors can discuss their needs directly with EKF personnel in live chats during designated hall hours from 10am to 12pm (EDT) on 10 – 13th and 15 – 17th June.

Key product highlights from EKF include the Lucicaยฎ Glycated Albumin-L manufactured by Asahi Kasei Pharma. This test is FDA cleared for sale in the U.S. and sold exclusively by EKF as a specific intermediate glycemic control marker. It delivers a specific quantitative determination of glycated albumin (GA) in serum on compatible clinical chemistry analyzers with open channel capability. The Lucicaยฎ GA has been one of the most widely used and published enzymatic GA methods in the world.

EKF also offers multiple options for measurement of Beta-Hydroxybutyrate (BHB), the main ketone-body produced during diabetic ketoacidosis (DKA). Measuring the level of BHB is clinically useful in both diagnosing ketoacidosis earlier and monitoring the results of treatment.

The LiquiColorยฎ B-HB test features liquid, โ€˜ready to useโ€™ reagents and is intended for the quantitative measurement of BHB with serum or plasma on compatible clinical chemistry analyzers with open channel capability. LiquiColorยฎ B-HB is used in more than 1300 laboratories in the U.S.

Also to be introduced is EKFโ€™s new STAT-Siteยฎ WB, a point-of-care Beta-Hydroxybutyrate and Glucose testing device. The STAT-Site WB dual analyte measurement system is CLIA waived, easy to use and provides reliable quantitative results in just 5-10 seconds. It is intended for whole blood multiple-patient use in professional healthcare settings as an aid to monitor the effectiveness of a diabetes control program.

About EKF Diagnosticsย 

EKF Diagnostics Holdings plc, which includes the EKF Diagnostics, Stanbio Laboratory and DiaSpect brands, specializes in the development, production and worldwide distribution of point-of-care analyzers for use in the detection and management of diabetes and anemia, and also in sports and maternal medicine. EKF products are sold in more than 100 countries around the globe, through a network of specialist distributors.

Point-of-care diagnostics: EKF Diagnostics designs and manufactures world-class diagnostic devices, as well as distributing rapid test kits for infectious diseases and pregnancy. The EKF analyzer range is used widely in GP surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for glucose, lactate, hemoglobin, hematocrit and HbA1c measurement.

Central laboratory: EKF, through its wholly owned subsidiary, Stanbio Laboratory (Boerne, Texas, USA), manufactures a comprehensive range of clinical chemistry reagents, as well as associated analyzers. In addition, EKF Life Sciences (Elkhart, Indiana, USA) manufactures enzymes used in reagent development and also provides contract fermentation facilities.

Data Science Helps Guide Memorial Health System During COVID-19 Pandemic

Data Science Helps Guide Memorial Health System During COVID-19 Pandemic

The power of data science is allowing officials at Memorial Health System to constantly track positive COVID-19 cases and hospital bed capacity, ensure timely test results and detect emerging โ€œhot spotsโ€ in communities.

Memorialโ€™s data team built a custom automated network to effectively guide the systemโ€™s response to the pandemic and preparations for the future, according to Lance Millburg, system director of decision sciences.

Beginning in mid-March, a team of data scientists and data engineers from the nonprofit system joined Millburg and other Memorial managers in working 60- and 70-hour weeks to write thousands of lines of code in SQL and Python that extracted real-time local, state and national data on COVID-19 cases.They grouped the information in databases that could be queried and examined in a Microsoft SQL Server environment, and used Tableau to create a dashboard for system leadersโ€™ daily command-center meetings.

โ€œIf this hadnโ€™t been in place, there would have been a lot more resources dedicated to manually count and track,โ€ Millburg said. โ€œThose resources were no longer tasked with that. They were tasked with taking care of patients.โ€

The system did not incur any new expense for hardware or software, said Millburg, a former computer programmer and database engineer who holds a masterโ€™s in business administration.

Memorial Health System, based in a state capital city of 115,000 people, employs 10,000 people throughout central Illinois. The system operates a 500-bed flagship institution, Memorial Medical Center, as well as four other hospitals and a total of eight affiliates.

The innovations adopted by the system amount to a โ€œnew frontierโ€ for organizations that serve patients and communities outside the nationโ€™s major cities, Millburg said.

โ€œThereโ€™s an opportunity for midsize and smaller institutions to do this work and do it in a cost-effective way,โ€ he said. โ€œIt was a very valuable tool for us. The way we went about doing this is very much a flexible infrastructure that many smaller hospitals would very easily be able to work with as long as they have the talent in place.โ€

As the pandemic went on, the decision sciences team pulled data from the systemโ€™s supply-chain software and used a custom application to analyze data on the use of personal protective equipment, a task that previously required someone to manually enter the information on spreadsheets. As a result, the organization was able to precisely compute โ€œburn ratesโ€ for PPE โ€” knowledge that was critical because of the increased need and diminished supply.

Memorial also was able to monitor processing times for COVID-19 tests and reroute test samples to various lab processing partners based on where the fastest turnarounds were available, Millburg said. And real-time tracking of bed capacity informed the systemโ€™s decision to designate its two largest hospitals as the sites where the sickest COVID-19 patients should be taken if a surge in cases takes place, he said.

The impact of data science has been far-reaching, Millburg said. At the beginning of the pandemic, data pulled from electronic health records allowed Memorial to conduct accurate contact tracing for all employees who came in contact with patients later deemed to be potentially infected so employees could self-quarantine or get tested themselves.

The health system has begun to use geospatial mapping tools that could help it work with local public health officials to intervene in certain neighborhoods and communities if case counts climb later this year, Millburg said.

Data-related innovations fueled by the pandemic could give the system better surveillance of other communicable diseases, as well, such as influenza and strep throat, he said.

Jones Healthcare Group Invests in New High-Performance Uhlmann Blister Packaging Line

Jones Healthcare Group Invests in New High-Performance Uhlmann Blister Packaging Line

Jones Healthcare Group, a market leader in advanced packaging and medication dispensing solutions, announces a significant investment in its packaging services offering including a new, fully integrated two-lane Uhlmann blister packaging line. The highly automated equipment will enhance the firmโ€™s capacity to manage demand surges and unique blister combinations, as more complex pharmaceutical dosage forms and regimes evolve clinically and commercially.

โ€œOur new line offers the highest quality, productivity and flexibility for blister packaging in a Health Canada and FDA-registered facility, including a full serialization and aggregation solution for prescription medicines,โ€ says Marty Quesnel, Senior Vice President โ€“ Packaging Services at Jones. โ€œWeโ€™re proud to work with world-class pharmaceutical equipment manufacturer Uhlmann to expand our offering with state-of-the-art technology.โ€

Fully compliant with the Drug Supply Chain Security Act (DSCSA), the automated line includes a two-lane B 1440 blister machine and C 2305 cartoner, as well as end-of-line stretch-wrapping and bundling. The equipment is capable of multi-product blistering for more complex dosing regimens, and multi-product cartoning for combination packs. The line also integrates a wide range of forming and lidding films such as PVC, Alu+Alu and child-resistant formats, with compatibility for multiple products and carton formats.

โ€œNow more than ever, our pharmaceutical customers look to us to manage more of their packaging process. This helps them meet unprecedented demand for over-the-counter headache, cold and other respiratory products for our communities, while also pivoting resources to support the pandemic response,โ€ adds Ron Harris, President & CEO at Jones. โ€œOur ongoing investment in services and capabilities ensures healthcare companies can continue to count on us as a reliable, resilient supply chain partner.โ€

The new line will be installed at the companyโ€™s Brampton, Canada facility and is anticipated to be operational early next year.

Translate ยป